Over the past 12‑18 months the Dog and Cat Calcium Tablet market has accelerated through a blend of strategic alliances, product innovation, and regulatory shifts. In March 2023, PetNutra partnered with VetoPharm to co‑develop a chewable calcium tablet enriched with marine‑derived vitamin D, expanding distribution across North America and Europe. The same year, AnimalHealth Holdings completed its acquisition of FelineWell, adding a line of feline‑specific calcium tablets and creating the first integrated pet‑nutraceutical platform. In September 2023, NutriPaws launched a patented micro‑encapsulation technology that protects calcium bioavailability through the acidic stomach environment, a breakthrough highlighted at the Global Pet Nutrition Expo. Regulatory momentum arrived in early 2024 when the EU revised its pet supplement labeling standards, prompting manufacturers to adopt transparent sourcing disclosures. Consumer data shows a 22 % rise in demand for joint‑support formulas that combine calcium with glucosamine, driving brands to broaden their portfolios. Finally, PetVenture Capital injected $45 million into a startup developing plant‑based calcium sources, signaling investor confidence in pet‑health solutions. These dynamics illustrate the evolving Dog and Cat Calcium Tablet industry trends that analysts are tracking closely.
